1
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, May 1, 2012: US08170675 (72 worldwide citation)

Selective high-frequency spinal chord modulation for inhibiting pain with reduced side affects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal chord region ...


2
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, June 26, 2012: US08209021 (61 worldwide citation)

Selective high-frequency spinal chord modulation for inhibiting pain with reduced side affects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 kHz to about 50 kHz may be applied to the patient's spinal chord region ...


3
Konstantinos Alataris, Andre B Walker: Extended pain relief via high frequency spinal cord modulation, and associated systems and methods. Nevro Corporation, Perkins Coie, February 11, 2014: US08649874 (58 worldwide citation)

Extended pain relief via high frequency spinal cord modulation, and associated systems and methods. A method for treating a patient in accordance with a particular embodiment includes selecting a neural modulation site to include at least one of a dorsal root entry zone and dorsal horn of the patien ...


4
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, January 22, 2013: US08359103 (51 worldwide citation)

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region t ...


5
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, January 22, 2013: US08359102 (51 worldwide citation)

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region t ...


6
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, January 15, 2013: US08355792 (46 worldwide citation)

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region t ...


7
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, April 23, 2013: US08428748 (42 worldwide citation)

Selective high-frequency spinal chord modulation for inhibiting pain with reduced side affects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal chord region ...


8
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, March 12, 2013: US08396559 (40 worldwide citation)

Selective high-frequency spinal chord modulation for inhibiting pain with reduced side affects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal chord region ...


9
Konstantinos Alataris, Andre B Walker, James R Thacker: Devices for controlling high frequency spinal cord modulation for inhibiting pain, and associated systems and methods, including simplified controllers. Nevro Corporation, Perkins Coie, April 16, 2013: US08423147 (37 worldwide citation)

In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal chord region to address low back pain without creating unwanted sensory and/or motor side affects. In other embodiments, modulation in accordance with simila ...


10
Konstantinos Alataris, Andre B Walker, Jon Parker, Yougandh Chitre, Sangsoo Wesley Park, James R Thacker: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods. Nevro Corporation, Perkins Coie, April 29, 2014: US08712533 (33 worldwide citation)

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region t ...